Objective

2

To systematically review research on

Xinsuning Capsules

in the treatment of ventricular premature contraction （VPC） and clarify its efficacy and characteristics.

Methods

2

Data from questionnaires， real-world studies， and published literature were collected. A comprehensive clinical evaluation of

Xinsuning Capsules

was conducted across the "6 + 1" dimensions： effectiveness， safety， economy， innovation， suitability， accessibility， and cha

racteristics of traditional Chinese medicine （TCM）.

Results

2

① Safety： Adverse reactions of

Xinsuning Capsules

include nausea， vomiting， abdominal pain， and heartburn. Pre-market safety studies， including acute and long-term toxicity tests， showed no significant adverse effects. The pharmacovigilance system is robust. ② Effectiveness：

Xinsuning Capsules

can reduce the frequency of VPC. Its effectiveness， whether used alone or combined with conventional antiarrhythmic Western medicine， is superior to conventional therapy alone. Comprehensive evaluation of evidence quality and value indicates sufficient effectiveness with clear results. ③ Economy：

Xinsuning Capsules

are included in Category B of the national medical insurance. Compared with similar products， its cost is low， and no additional expenses are incurred during treatment. Comprehensive quality and value evaluation indicate good economic performance. ④ Innovation：

Xinsuning Capsules

are derived from the ancient formula Huanglian Wendan Decoction （Systematic Differentiation of the Six Etiologies）， modified according to modern pharmacological research on the antiarrhythmic effects of Dichroae Radix and Artemisiae Annuae Herba. ⑤ Suitability： Questionnaire results indicate that the drug has good suitability for clinicians， nurses， and patients in terms of preparation， storage， and use. ⑥ Accessibility： The treatment course costs 2 370 yuan， with a defined daily cost of 79 yuan. The product is available in 27 provinces and municipalities and 3 000 hospitals. Evaluation of price， affordability， and availability shows good accessibility. ⑦ Characteristics of TCM：

Xinsuning Capsules

， derived from the modified Huanglian Wendan Decoction， clear heat， resolve phlegm， calm the heart， and stabilize palpitations. Based on 1 842 post-marketing cases， clinical studies， and enterprise-provided research reports， sufficient evidence and clear results were obtai

ned for the TCM characteristics dimension. ⑧ Comprehensive clinical value evaluation： Based on the above “6 + 1” dimensions，

Xinsuning Capsules

demonstrates sufficient evidence of clinical value with clear results.

Conclusion

2

Xinsuning Capsules

have sufficient evidence for safety and accessibility； effectiveness， economy， innovation， and suitability have relatively sufficient evidence with clear results； TCM characteristics are prominent. Comprehensive clinical value evaluation indicates sufficient evidence and clear outcomes.